Stock Research for INFI

Current Price


Latest Update: 2018-02-16 16:00:00

$ 1.8600
$ 1.8400
$ 1.8600

Featured Broker: TradeStation

Get the due diligence for another stock.


INFI Stock Chart & Research Data

The INFI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the INFI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


INFI Due diligence Resources & Stock Charts

The INFI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View INFI Detailed Price Forecast - CNN Money CNN View INFI Detailed Summary - Google Finance
Yahoo View INFI Detailed Summary - Yahoo! Finance Zacks View INFI Stock Research & Analysis -

Stock Analysis

TradeIdeas View INFI Trends & Analysis - Trade-Ideas Barrons View INFI Major Holders - Barrons
NASDAQ View INFI Call Transcripts - NASDAQ Seeking View INFI Breaking News & Analysis - Seeking Alpha
Spotlight View INFI Annual Report - OTC Report View INFI OTC Short Report -
TradeKing View INFI Fundamentals - TradeKing Charts View INFI SEC Filings - Bar Chart
WSJ View Historical Prices for INFI - The WSJ Morningstar View Performance/Total Return for INFI - Morningstar
MarketWatch View the Analyst Estimates for INFI - MarketWatch CNBC View the Earnings History for INFI - CNBC
StockMarketWatch View the INFI Earnings - StockMarketWatch MacroAxis View INFI Buy or Sell Recommendations - MacroAxis
Bullish View the INFI Bullish Patterns - American Bulls Short Pains View INFI Short Pain Metrics -

Social Media Mentions

StockTwits View INFI Stock Mentions - StockTwits PennyStocks View INFI Stock Mentions - PennyStockTweets
Twitter View INFI Stock Mentions - Twitter Invest Hub View INFI Investment Forum News - Investor Hub
Yahoo View INFI Stock Mentions - Yahoo! Message Board Seeking Alpha View INFI Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for INFI - Insider Cow View Insider Transactions for INFI - Insider Cow
CNBC View INFI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for INFI - OTC Markets
Yahoo View Insider Transactions for INFI - Yahoo! Finance NASDAQ View Institutional Holdings for INFI - NASDAQ

Stock Charts

FinViz View INFI Stock Insight & Charts - StockCharts View INFI Investment Charts -
BarChart View INFI Stock Overview & Charts - BarChart Trading View View INFI User Generated Charts - Trading View

Latest Financial News for INFI

Research Report Identifies TESARO, Brunswick, Brooks Automation, Infinity Pharmaceuticals, Edison International, and Anthem with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
Posted on Friday February 16, 2018

NEW YORK, Feb. 16, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of TESARO, ...

Infinity To Present At BIO CEO & Investor Conference
Posted on Monday February 05, 2018

CAMBRIDGE, Mass. , Feb. 5, 2018 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) announced today that Adelene Perkins , Infinity Pharmaceutical's chief executive officer, will present at the ...

Infinity Provides Update on Lead Candidate, Issues 2018 View
Posted on Friday January 26, 2018

Infinity (INFI) announces the achievement of some development milestones for its lead pipeline candidate- IPI-549 and issued financial guidance for 2018.

Infinity Provides Update on IPI-549 Phase 1/1b Study, 2018 Goals and Financial Guidance
Posted on Monday January 08, 2018

CAMBRIDGE, Mass., Jan. 8, 2018 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (INFI) today announced the achievement of four development milestones for IPI-549, a first-in-class, oral, immuno-oncology product candidate targeting tumor-associated myeloid cells through selective phosphoinositide-3-kinase-gamma (PI3K-gamma) inhibition, thereby reducing pro-tumor macrophage function and increasing anti-tumor macrophage function. First, the Phase1/1b monotherapy expansion component of the study has been fully enrolled.

Infinity Pharmaceuticals: When Safety Is A Win
Seeking Alpha - Nov 10, 2017
Shares of Infinity Pharmaceuticals (INFI) are currently in the red by 17% or so in the premarket session as I write this update piece.

Infinity Pharmaceuticals: Oral Presentation Implies Near-Term Upside
Seeking Alpha - Oct 12, 2017
Shares have risen over 40% in the premarket as I write this, but I believe more upside is ahead. The company´s late-breaking oral presentation in November is an important near term catalyst.
Infinity Pharmaceuticals Notches Upgrade Ahead Of Cancer Conference Presentation - Benzinga
Taking a Fresh Look at Infinity Pharmaceuticals, Inc. (INFI) - StockNewsJournal

Infinity Pharmaceuticals, Inc. (INFI) Analysts See $-0.25 EPS
Frisco Fastball - 20 hours ago
49,500 are held by Nationwide Fund Advsr. Acadian Asset Mngmt Limited Liability Company accumulated 36,984 shares or 0% of the stock.
Infinity Pharmaceuticals, Inc. (INFI) EPS Estimated At $-0.25 - BZ Weekly
Infinity Pharmaceuticals (INFI) Given Daily News Impact Rating of 0.38 - The Ledger Gazette

Infinity Pharmaceuticals Inc. (INFI) Plunges 7.61% on February 12 - Feb 12, 2018
Infinity Pharmaceuticals Inc. (INFI) had a rough trading day for Monday February 12 as shares tumbled 7.61%, or a loss of $-0.15 per share, to close at $1.82.
Hot Stock to Watch: Infinity Pharmaceuticals, Inc. (INFI) - FactsReporter
Infinity Pharmaceuticals, Inc. (INFI): A Detailed Look at its Institutional ... - Post Analyst

Enter a stock symbol to view the stock details.